Your Directors’ take pleasure in presenting the Annual Report on the business and operations of your Company together with theaudited financial statements for the year ended 31st March, 2025.
Your directors are pleased to inform that the Composite Scheme of Arrangement between Chembond Material TechnologiesLimited (formerly Chembond Chemicals Limited) (“Demerged Company” / “Transferee Company”) and Chembond ChemicalsLimited (formerly Chembond Chemical Specialties Limited) (“Resulting Company”) and Chembond Clean Water TechnologiesLimited (“Transferor Company No. 1” Or “CCWTL”) and Chembond Material Technologies Private Limited (“Transferor CompanyNo. 2” Or “CMTPL”) and Phiroze Sethna Private Limited (“Transferor Company No. 3” Or “PSPL”) and Gramos Chemicals (India)Private Limited (“Transferor Company No. 4” Or “GCIPL”) and their respective shareholders has been sanctioned by the Hon’bleNational Company Law Tribunal, Mumbai Bench (NCLT) vide its order dated April 7, 2025 and certified copy of the order wasreceived by Demerger Company on April 22, 2025. The Scheme of Arrangement became effective upon filing the NCLT order withthe Registrar of Companies on May 3, 2025. In accordance with the Scheme, the ‘Appointed Date’ is April 1,2024.
The restated financial performance of your Company is as summarized below for the year under review:
Particulars
Standalone
Consolidated
2024-25
2023-24
Revenue from Operations
6940.04
6886.05
29227.34
28323.95
Other Income
381.08
376.54
582.98
370.43
Total Income
7321.12
7262.59
29810.32
28694.38
Total expense
6562.72
6162.46
25593.34
24449.58
Profit before taxes and exceptional items
758.39
1103.13
4216.98
4244.80
Profit before taxes after exceptional items
Provision for taxation for the year including deferredtax
155.53
360.10
1125.53
1242.51
Profit after Taxes
602.86
743.03
3091.45
3001.79
Share of Profit(loss) of Step Down Associate
-
0.45
0.50
Profit for the year
3091.90
3002.29
solutions for water treatment, industrial and institutionalcleaning and hygiene, and high-performance constructionchemicals.
The Board of Directors has recommended a final dividendof T1.25 per share for the financial year ended 31st March2025. This includes a special dividend of T0.50 per share tocommemorate the 50th anniversary of the founding of theChembond Group.
Except for the realignment resulting from the implementationof the Composite Scheme of Arrangement duly approved by theNCLT, Mumbai vide their order dated April 7, 2025 there is noother change in the nature of business or the business line ofthe Company. We are engaged in the manufacturing and salesof specialty chemicals. Your Company offers comprehensive
The Board of Directors of the Company at its meeting held on 12thDecember 2023 approved the Composite Scheme of Arrangementbetween:
1. Chembond Chemicals Ltd, now known as Chembond MaterialTechnologies Ltd ("Demerged Company"/ "TransfereeCompany"), and
2. Chembond Chemical Specialties Ltd, now known asChembond Chemicals Ltd ("Resulting Company"), and
3. Chembond Clean Water Technologies Ltd ("TransferorCompany No. 1" or "CCWTL"), and
4. Chembond Material Technologies Pvt Ltd ("TransferorCompany No. 2" or "CMTPL"), and
5. Phiroze Sethna Pvt Ltd ("Transferor Company No. 3" or"PSPL"), and
6. Gramos Chemicals (India) Pvt Ltd ("Transferor Company no.4" or "GCIPL"), and
7. their respective shareholders under Section 230-232 andother applicable provisions of the Act.
The Scheme envisages the transfer of the construction chemicalsand water treatment ("CC & WT") businesses to its whollyowned subsidiary ("WOS") Chembond Chemical SpecialtiesLtd (since renamed as Chembond Chemicals Ltd) by way ofdemerger and, post demerger amalgamation of CCWTL with theResulting Company. The National Company Law Tribunal (NCLT)has approved the scheme vide its order dated April 7, 2025.The Company has filed INC 28 on May 3, 2025, and accordingly,the Scheme has become effective from Saturday, May 3, 2025.Pursuant to Clause 42 of the Composite Scheme of Arrangement,the name of the Company has been changed from 'ChembondChemical Specialties Ltd' to 'Chembond Chemicals Ltd' with effectfrom June 24, 2025.
The movement of Equity Capital is as under:
No. of EquityShares
Equity ShareCapital (?)
Equity Capital as onDecember 12, 2023
10000
50,000
Increase/ Decreaseduring the year
Nil
Equity Capital as on 31stMarch 2024
10,000
Allotment of shares asper Composite Schemeof arrangement on May13, 2025
2,68,96,576
13,44,82,880
Cancellation of originalshare capital held byChembond MaterialTechnologies Limited(formerly known asChembond ChemicalsLimited) as percomposite scheme ofarrangement
(10,000)
(50,000)
Equity Capital as on May13, 2025
Pursuant to and in accordance to the above-referred NCLTapproved Scheme, the Allotment Committee has allotted2,68,96,576 (Two Crores Sixty-Eight Lakhs Ninety-SixThousand Five Hundred Seventy-Six) new equity shares of
face value T5/- each (Rupees Five) to the eligible shareholdersof Chembond Chemicals Ltd, now known as ChembondMaterial Technologies Ltd, (“Demerged Company” ), at a shareentitlement ratio of 1:2 (two new equity share for every oneshares held) as on the record date, which was Friday, May 9,2025.
The Allotment Committee noted the cancellation andreduction of the entire pre-Scheme paid-up share capital ofthe Resulting Company, comprising 10,000 (Ten Thousand)fully paid-up equity shares of face value T5/- each (“ResultingCompany Cancelled Shares”), which were held entirely byChembond Chemicals Ltd (“Demerged Company”). Thereduction in share capital of the Resulting Company is anintegral part of the scheme in accordance with the provisionsection 66 of the Companies Act 2013 and/or any otherapplicable provision of the Act without any further act or deedon the part of Resulting Company and without any approvalor acknowledgement of any third party. With the allotment ofthe new equity shares and the cancellation of the ResultingCompany Cancelled Shares, as outlined above, the ResultingCompany will no longer be considered a WOS of the DemergedCompany, in accordance with the provisions of the Scheme.Your Company has only one class of Equity Shares and it hasneither issued shares with differential rights for dividend,voting or otherwise, nor issued shares (including sweat equityshares) to the employees or Directors of the Company, underany Scheme. No disclosure is required under Section 67(3)(c)of the Act in respect of voting rights not exercised directly bythe employees or Key Managerial Personnel of the Companyas the provisions of the Section are not applicable.
The Company is in the process of the listing of 2,68,96,576 (TwoCrores Sixty-Eight Lakhs Ninety-Six Thousand Five HundredSeventy-Six) new equity shares of face value T5/- each on BSELtd [BSE] and the National Stock Exchange of India Ltd [NSE].The shares will be listed upon receipt of the requisite listingand trading approvals from the respective stock exchanges.
The Company has not accepted any deposits within themeaning of Section 73 of the Act read with the Companies(Acceptance of Deposits) Rules, 2014 as amended from timeto time.
In accordance with the provisions of Section 152(6) of theCompanies Act, 2013, Mr. Sameer V. Shah (DIN: 00105721)Non-Executive Director, retires by rotation at the ensuingAnnual General Meeting, and being eligible, has offeredhimself for re-appointment. His profile is detailed in theCorporate Governance Report, which forms a part of thisAnnual Report.
Mrs. Rashmi Gavli (DIN: 08001649) resigned as a Non¬Executive Director with effect from April 1, 2025. The Boardplaces on record its appreciation for her contributions duringher tenure with the Company.
The Board appointed Mrs. Anuradha Paraskar (DIN: 02331564)and Prof. Aniruddha B. Pandit (DIN: 02471158) as IndependentNon-Executive Directors of the Company with effect fromApril 1, 2025, for a term of five years. The Board appointedMr. Sushil U. Lakhani (DIN: 01578957) and Mr. MahendraK. Ghelani (DIN: 01108297) as Independent Non-ExecutiveDirectors of the Company with effect from May 6, 2025, for aperiod of five years. Their appointments were duly approved bythe Members through an Extraordinary General Meeting by therequisite majority.
In terms of key managerial changes, the Company appointedMrs. Prachi Mahadik as its Chief Financial Officer with effectfrom April 1, 2025, and Mr. Kiran Mukadam as its CompanySecretary and Compliance Officer with effect from May 6,2025.
Pursuant to the provisions of Section 203 of the CompaniesAct, 2013, Mr. Nirmal V. Shah, Chairman and ManagingDirector; Mrs. Prachi Mahadik, Chief Financial Officer; and Mr.Kiran Mukadam, Company Secretary and Compliance Officerare the Key Managerial Personnel of the Company as on thedate of this Report.
All the Independent Directors of the Company have furnisheda declaration to the effect that they meet the criteria ofindependence as provided in Section 149(6) of the Act andRegulation 16(1)(b) and Regulation 25 of the Listing Regulations.The Board opines that all the Independent Directors possessthe integrity, expertise, experience, and proficiency requiredto be Independent Directors of the Company, fulfil theconditions of independence as specified in the Act and theListing Regulations, are independent of the management,and have complied with the Code for Independent Directorsas prescribed in Schedule IV of the Act. Declaration of theirindependence as required under the Listing Regulations havealso been received from the Directors.
The Company has put in place an appropriate policy onappointment and remuneration of Directors and other mattersprovided under Section 178(3) of the Act. This policy is uploadedon the Company’s website https://www.chembondindia.com/all-policies/. Salient features of the policy on remuneration ofDirectors have been disclosed in the Corporate Governancesection of this Annual Report.
Four (4) meetings of the Board were held during the yearunder review, details of which are furnished in the CorporateGovernance Report forming part of the Annual Report.
During the year under review, the provisions relating tothe Nomination and Remuneration Committee and therequirement for a separate meeting of Independent Directorswere not applicable to the Company. Accordingly, theevaluation of the performance of Non-Independent Directors,the Board as a whole, and the Chairman was not required.Correspondingly, the assessment of the quality, quantity, andtimeliness of the flow of information to the Board, as reviewedby the Independent Directors for the effective and reasonabledischarge of its duties, was also not applicable.
Pursuant to Section 134(5) of the Act, the Board of Directors,to the best of their knowledge and ability, in respect of the yearended 31st March, 2025, confirm that:
(a) in the preparation of the annual accounts, the applicableaccounting standards have been followed and there areno material departures;
(b) they had selected such accounting policies and appliedthem consistently and made judgments and estimatesthat are reasonable and prudent so as to give a true andfair view of the state of affairs of the Company at the endof the financial year and of the profit of the Company forthat period;
(c) they took proper and sufficient care for the maintenanceof adequate accounting records in accordance with theprovisions of this Act for safeguarding the assets of theCompany and for preventing and detecting fraud andother irregularities;
(d) they prepared the annual accounts on a going concernbasis;
(e) they laid down internal financial controls to be followedby the Company and that such internal financial controlsare adequate and were operating effectively; and
(f) they devised proper systems to ensure compliancewith the provisions of all applicable laws and that suchsystems were adequate and operating effectively.
The details in respect of role/powers/composition of theAudit Committee and other information are included in theCorporate Governance Report forming part of this AnnualReport.
M/s. Bathiya & Associates, LLP, Chartered Accountants(FRN:101046W/W100063) name changed to S H B A & COLLP were appointed for first term as the Statutory Auditor ofthe Company for a period of 5 (five) consecutive years at the1st Annual General Meeting (AGM) held on July 20, 2024 untilthe conclusion of the 6th AGM to be held in the FY 2029 at aremuneration as may be mutually agreed upon by the Board ofDirectors and the Statutory Auditor.
The Report given by the Auditors on the financial statementsof the Company is part of this Report. There has been nomodified opinion, qualification, reservation, adverse remarkor disclaimer given by the Auditors in their Report during theyear under review and the observations and comments givenin the report of the Statutory Auditors read together with Notesto Accounts are self-explanatory and hence do not call for anyfurther explanation or comments under Section 134 (f)(i) ofthe Act.
During the year under review, the Statutory Auditor, CostAuditor and Secretarial Auditor have not reported anyinstances of frauds committed in the Company by its officersor employees, to the Audit Committee under Section 143(12)of the Act details of which needs to be mentioned in thisAnnual Report.
The Company has been carrying on its domestic andinternational operations through its wholly owned subsidiaries,step-down subsidiaries, and step-down associate Companies.The details of financial performance of these companies aregiven in AOC-I as Annexure A.
Further, pursuant to the provisions of Section 136 of theAct, the standalone financial statements of the Company,consolidated financial statements along with relevantdocuments and separate audited financial statements inrespect of subsidiaries, are available on the Company’swebsite https://www.chembondindia.com/subsidiary-
financials/.
Pursuant to the Composite Scheme of Arrangement andNCLT order dated April 7, 2025, Chembond Clean WaterTechnologies Ltd stands amalgamated on May 3, 2025.
All transactions entered into with related parties during thefinancial year were in the ordinary course of business and onarm’s length basis and do not attract the provisions of Section188(1) of the Act. Suitable disclosures as required by theIndian Accounting Standards (Ind AS-24) have been made in
the notes to the Financial Statements. The Board has a policyfor related party transactions which has been uploaded on theCompany’s website https://www.chembondindia.com/all-policies/. Material RPT entered during the year are attachedas Annexure B in Form No. AOC-2, prescribed under theprovisions of Section 134(3)(h) of the Act and Rule 8 of theCompanies (Accounts) Rules, 2014.
The Conservation of Energy, Technology Absorption,Foreign Exchange Earnings and Outgo
The particulars relating to conservation of energy, technologyabsorption and foreign exchange earnings and outgo, asrequired to be disclosed under Section 134(3)(m) of the Actread with Rule 8(3) of the Companies (Account) Rules, 2014,as amended from time to time, are provided in Annexure C.
Pursuant to Section 135 of the Act read with the Companies(Corporate Social Responsibility Policy) Rules, 2014 asamended from time to time, the Board of Directors ofthe Company has duly constituted the Corporate SocialResponsibility (CSR) Committee, adopted CSR policy. TheCSR policy is available on Company’s website at https://www.chembondindia.com/all-policies/.
During the year, the Company was not subject to theCorporate Social Responsibility (CSR) spending obligation,as it did not meet the eligibility criteria prescribed underSection 135(1) of the Companies Act, 2013. However, the CSRobligations were applicable to Chembond Water TechnologiesLimited (WOS) and Chembond Clean Water TechnologiesLimited which was amalgamated with the Company onMay 3, 2025. These companies spent Rs. 47.96 lakhs andRs. 8.07 lakhs, respectively, on CSR activities during the financialyear 2024-25 through Visan Trust. The Company has identifiedkey focus areas for CSR engagement, which are detailed in theAnnual Report on CSR Activities, attached as Annexure D.
Pursuant to the provisions of Section 204 of the Act and theCompanies (Appointment and Remuneration of ManagerialPersonnel) Rules, 2014, the Board of Directors of the Companyhas appointed Mr. Virendra G. Bhatt, Practicing CompanySecretary (C.P. No.: 124) to undertake the Secretarial Auditof the Company for the year ended 31st March, 2025. TheCompany has received their written consent and confirmationthat the appointment will be in accordance with the applicableprovisions of the Act and rules framed thereunder.
The Secretarial Audit Report in Form MR- 3 for the FinancialYear ended 31st March, 2025 has been annexed as AnnexureE. The Company has complied with the applicable SecretarialStandards issued by the Institute of Company Secretaries
of India (ICSI) during the year under review. There are noqualification, reservation, adverse remark or disclaimer givenby the Secretarial auditor in their report for the year underreview.
Information regarding Directors’ Remuneration Policy &criteria for determining qualifications, positive attributes,independence of a director and other matters provided undersub-section (3) of Section 178 are provided in the CorporateGovernance Report.
The statement containing particulars of employees asrequired under Section 197 of the Act read with Rule 5(2) of theCompanies (Appointment and Remuneration of ManagerialPersonnel) Rules, 2014, as amended, will be providedupon request to the Company. None of the employees ofthe Company are being paid remuneration exceeding theprescribed limit under the said provisions and Rules.
In terms of Section 136 of the Act, the Report and Accountsare being sent to the members and others entitled thereto,excluding the information on employees’ particulars whichis available for inspection by the members at the registeredoffice of the Company during business hours on working daysof the Company up to the date of the ensuing Annual GeneralMeeting
In terms of the provisions of the Act and the Listing Regulations,the Company has adopted all the applicable policies. Thepolicies are available on the website of the Company athttps://www.chembondindia.com/all-policies/.
All Directors and Senior Management Personnel have affirmedtheir adherence to the provisions of the Code of Conductduring the FY 2024-25. The Company’s policy on Directors’appointment, remuneration and other matters providedin Section 178(3) of the Act forms part of Nomination andRemuneration Policy and has been disclosed in the CorporateGovernance Report.
As per the requirements of the Listing Regulations, a RiskManagement Committee was constituted voluntarily withresponsibility of preparation of Risk Management Plan,reviewing and monitoring the same on regular basis, to identifyand review critical risks on regular basis, to report key changesin critical risks to the Board on an on-going basis, to reportcritical risks to Audit Committee in detail on yearly basis andsuch other functions as may be prescribed by the Board. TheCompany has its Risk Management Policy in place which isalso displayed on the website of the Company i.e. https://www.chembondindia.com/all-policies/.
The Board is responsible for establishing and maintainingadequate internal financial control as per Section 134 ofthe Act. Your Company has in place an adequate system ofinternal controls to ensure compliance with various policies,practices and statutes. The Company maintains robustinternal financial controls systems and processes that arecommensurate with the size, nature, geographical spread andcomplexities of its operation both at entity and process levelsof the Company.
Management Discussion and Analysis Report for the yearunder review, as stipulated under the Listing Regulations, ispresented , forming part of this Annual Report.
A separate Corporate Governance Report on compliancewith Corporate Governance requirements as requiredunder Regulation 34(3) read with Schedule V of the ListingRegulations forms part of this Annual Report. The same hasbeen reviewed and certified by Mr. Virendra G. Bhatt, PracticingCompany Secretary, the Secretarial Auditor of the Companyand Compliance Certificate in respect thereof is enclosed.
The Company has formulated a Whistle Blower Policy,details of which are furnished in the Corporate GovernanceReport, thereby establishing a vigil mechanism for Directorsand permanent employees for reporting genuine concernsor grievances, if any, about unethical behaviour, actual orsuspected fraud or violation of Company’s Code of Conductor policies. It also provides adequate safeguards against thevictimization of employees and allows direct access to thechairperson of Audit Committee in appropriate or exceptionalcases. The vigil mechanism / whistle blower policy is availableon Company’s website https://www.chembondindia.com/all-policies/.
Details of loans, guarantees and investments have beendisclosed in the Financial Statements.
The Company has in place an Anti-Sexual Harassment Policyin line with the requirements of the Sexual Harassment ofWomen at Workplace (Prevention, Prohibition and Redressal)Act, 2013. The policy for Prevention of Sexual Harassment atworkplace is available on the website of the Company https://www.chembondindia.com/all-policies. Internal ComplaintsCommittee (ICC) has been set up to redress complaintsreceived regarding sexual harassment. All employees
(permanent, contractual, temporary and trainees) are coveredunder this policy. They are also provided training about theAct. During the year under review, no complaint was received.
The Business Responsibility and Sustainability Report for theyear ended 31st March, 2025 as stipulated under Regulation 34of the Listing Regulations is not applicable to the Company.
Except as disclosed elsewhere in the Report, there havebeen no material changes and commitment affecting (exceptmentioned in share capital , name change and scheme ofarrangement related point) , the financial position of yourCompany, which have occurred between the end of thefinancial year of the Company and the date of this Report.
During the year under review, there is no pending litigationagainst the Company and its Directors. There has been nosignificant and material order passed by the Regulators orCourts or Tribunals impacting the going concern status of theCompany and its future operations.
The Company recognizes the need to have well-equippedR&D facilities to meet customer requirements and to developcutting edge products. As a natural corollary, your Companycontinues to invest in a R&D programme with processes thatsuit the business and strategy of the Company.
The Board of Directors places on record its sincere appreciationfor the hard work, dedication, and commitment demonstratedby its personnel across all levels of the organization. TheBoard also gratefully acknowledges the continued supportand cooperation extended by the bankers, suppliers, businesspartners, members, various government authorities, and allother stakeholders who have contributed to the Company’sprogress.
By Order of the Board of Directorof Chembond Chemicals Limited
(formerly Chembond Chemical Specialties Limited)
Chairman & Managing Director
June 30, 2025, Navi Mumbai DIN-00083853